NISC-6

N/A

Report date: 2025/01/26 16:38:07

NME

Base Information

Drug NameNISC-6

Drug Alias NameAkt1 gene inhibitor (Pennsylvania State University)naphthalimide isoselenocyanate analog (Pennsylvania State University)topoisomerase II alpha inhibitor (Pennsylvania State University)NISC-6

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitorsSerine/threonine-protein kinase AKT1 inhibitors

TargetsSerine/threonine-protein kinase AKT1Topoisomerase (DNA) II alpha

Therapy Area/IndicationsMelanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPennsylvania State University

China Registration ClassN/A

Develop Information

Active CompaniesPennsylvania State University

Inactive CompaniesN/A

Active IndicationsMelanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A